doi:10.3969/j.issn.1673-8640.2023.03.017

Abstract

CLC Number:

R446.62

Figures/Tables 5

References 9

[1]	中华医学会妇产科学分会产科学组, 中华医学会围产医学分会. 乙型肝炎病毒母婴传播预防临床指南(2020)[J]. 中华妇产科杂志, 2020, 55(5):291-299.
[2]	YANG Y T, HUANG A L, ZHAO Y. The prevalence of hepatitis B core antibody in vaccinated Chinese children:a hospital-based study[J]. Vaccine, 2019, 37(3):458-463. DOI URL
[3]	BA ALAWI F, ROBERTSON P W, LEPAGE A K, et al. The reliability of HBV core antibody in serological screening for hepatitis B virus[J]. Pathology, 2013, 45(5):501-505. DOI URL
[4]	陈存存, 范列英. 抗HCV抗体和抗TP抗体筛查试验的假阳性问题及对策研究进展[J]. 检验医学, 2015, 30(12):1167-1174.
[5]	涂少华, 朱敏, 沈江帆. 光激化学发光法检测乙型肝炎病毒感染血清学标志的性能评价[J]. 检验医学, 2011, 26(7):452-456.
[6]	中国合格评定国家认可委员会. CNAS-GL038:2019 临床免疫学定性检验程序性能验证指南[S]. 北京: 中国合格评定国家认可委员会, 2019.
[7]	中华人民共和国国家卫生和计划生育委员会.WS/T 573—2018 感染性疾病免疫测定程序及结果报告[S]. 北京: 中华人民共和国国家卫生和计划生育委员会, 2018.
[8]	LIANG X, BI S, YANG W, et al. Reprint of:epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination[J]. Vaccine, 2013, 31(Suppl 9):J21-J28. DOI URL
[9]	中华人民共和国国家卫生和计划生育委员会.WS/T 494—2017 临床定性免疫检验重要常规项目分析质量要求[S]. 北京: 中华人民共和国国家卫生和计划生育委员会, 2017.

LiCA S/CO值	参考方法
LiCA S/CO值	阳性	阴性
阳性（0.00~1.00）	237	21
0.00~0.19	187	0
0.20~0.39	21	2
0.40~0.59	18	3
0.60~0.79	7	9
0.80~1.00	4	7
阴性（1.01~3.26）	3	184
1.01~1.99	3	86
2.00~2.99	0	86
3.00~3.26	0	12

LiCA S/CO值	参考方法
LiCA S/CO值	阳性	阴性
阳性（0.00~1.00）	237	21
0.00~0.19	187	0
0.20~0.39	21	2
0.40~0.59	18	3
0.60~0.79	7	9
0.80~1.00	4	7
阴性（1.01~3.26）	3	184
1.01~1.99	3	86
2.00~2.99	0	86
3.00~3.26	0	12

LiCA S/CO值	例数	参考方法		阳性预测值/%
LiCA S/CO值	例数	阳性	阴性	阳性预测值/%
1.00	258	237	21	91.86
0.90	255	236	19	92.55
0.80	247	233	14	94.33
0.77	245	233	12	95.10
0.75	242	231	11	95.45
0.72	239	230	9	96.23
0.69	237	229	8	96.62
0.65	235	229	6	97.45
0.61	231	226	5	97.84
0.50	220	216	4	98.18

LiCA S/CO值	例数	参考方法		阳性预测值/%
LiCA S/CO值	例数	阳性	阴性	阳性预测值/%
1.00	258	237	21	91.86
0.90	255	236	19	92.55
0.80	247	233	14	94.33
0.77	245	233	12	95.10
0.75	242	231	11	95.45
0.72	239	230	9	96.23
0.69	237	229	8	96.62
0.65	235	229	6	97.45
0.61	231	226	5	97.84
0.50	220	216	4	98.18

LiCA S/CO值	敏感性/%	特异性/%	Youden指数
0.55	92.50	97.56	0.900 6
0.60	94.17	97.56	0.917 3
0.65	95.42	97.07	0.924 9
0.68	95.42	96.10	0.915 2
0.74	96.25	94.63	0.908 8
0.78	97.08	93.66	0.907 4
0.82	97.08	91.71	0.887 9

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 9

Related Articles 15

Recommended Articles

Metrics

[1]	TANG Qingqin, QIAO Longwei, YIN Jingping, ZHANG Sheng, FENG Bin, LIANG Yuting. Correlation of peripheral blood monocyte count and serum anti-phospholipase A2 receptor antibody in patients with nephrotic syndrome [J]. Laboratory Medicine, 2023, 38(7): 647-652.
[2]	WANG Haiping, LI He. BISAP score combined with serum sRAGE for predicting hyperlipidemic acute pancreatitis severity and short-term prognosis [J]. Laboratory Medicine, 2023, 38(7): 653-658.
[3]	WU Jie, LI Zenghe, CHEN Baorong, KONG Xujing. Establishment of traceable steroid hormone standard curve for dried blood spot samples [J]. Laboratory Medicine, 2023, 38(5): 489-493.
[4]	. [J]. Laboratory Medicine, 2023, 38(1): 100-102.
[5]	. [J]. Laboratory Medicine, 2022, 37(9): 892-893.
[6]	SUN Xiaodan, LIU Yiwen, HE Yiqing, DU Yan, ZHANG Guoliang, GAO Feng, YANG Cuixia. Research progress on the role of estrogen receptor in osteosarcoma [J]. Laboratory Medicine, 2022, 37(4): 313-318.
[7]	SUN Xiaodan, XU Jing, LIU Yiwen, HE Yiqing, DU Yan, ZHANG Guoliang, GAO Feng, YANG Cuixia. Inhibitory effects of antiestrogen on the proliferation and CCL2 expression of osteosarcoma cells [J]. Laboratory Medicine, 2022, 37(4): 319-324.
[8]	CHEN Si, LIU Hua, LIU Yiwen, HE Yiqing, ZHANG Guoliang, YANG Cuixia, DU Yan, GAO Feng. Clinical significance of combined determination of serum HER-2 and CD44 in colorectal cancer [J]. Laboratory Medicine, 2022, 37(4): 336-341.
[9]	ZHAO Mingna, ZHANG Chenzi, HONG Qiushuang, LOU Jiatao. Mechanism of IL-8/miR-182 positive feedback regulatory axis in non-small cell lung cancer [J]. Laboratory Medicine, 2022, 37(4): 349-355.
[10]	ZHANG Zhibin, YANG Wanyong, RUAN Fuwang, WEN Qinghui. Roles of total IgE,sIgE and 25（OH）D in the evaluation of infant atopic dermatitis [J]. Laboratory Medicine, 2022, 37(3): 217-220.
[11]	. [J]. Laboratory Medicine, 2021, 36(12): 1264-1266.
[12]	QIU Fang, ZHU Ping, JIANG Peng, WANG Chan. Relation between anti-gp210 antibody,anti-sp100 antibody and ALBI score in patients with primary biliary cholangitis [J]. Laboratory Medicine, 2021, 36(11): 1106-1109.
[13]	. [J]. Laboratory Medicine, 2021, 36(9): 925-928.
[14]	LIU Yang, ZHANG Zhiping, PENG Daorong, SONG Liuwei, GE Shengxiang, HAO Xiaoke, LIU Jiayun. Establishment and performance evaluation of chemiluminescent microparticle immunoassay for the determination of high concentration HbsAg [J]. Laboratory Medicine, 2020, 35(10): 1056-1061.
[15]	. [J]. Laboratory Medicine, 2020, 35(9): 957-959.